IDH1 and central nervous system cancer: We further employed the MR-UM approach to investigate intraoperatively obtained resection material from two glioma patients, one with a glioblastoma (WHO grade IV, IDH1 wildtype) and one with an oligodendroglioma (WHO grade II, IDH1 mutant).